Autopsy validation study of the academic research consortium stent thrombosis definition

JACC: Cardiovascular Interventions

Volumn 4, Issue 5, 2011, Pages 554-559

  Cutlip, Donald E ^a,b   Nakazawa, Gaku ^d   Krucoff, Mitchell W ^e   Vorpahl, Marc ^c   Mehran, Roxana ^f   Finn, Aloke V ^d   Vranckx, Pascal ^g   Kimmelstiel, Carey ^b,c   Berger, Clifford ^b   Petersen, John L ^h   Palabrica, Theresa ^b   Virmani, Renu ^d,i  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d CVPATH INSTITUTE   (United States)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^f Och Spine at New York Presbyterian Hospitals   (United States)

^g CARDIALYSIS   (Netherlands)

^h SWEDISH MEDICAL CENTER   (United States)

ⁱ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

myocardial infarction; stent; thrombosis

Indexed keywords

ARTICLE; AUTOPSY; CAUSE OF DEATH; CORONARY STENT; FALSE POSITIVE RESULT; HUMAN; PRIORITY JOURNAL; STENT THROMBOSIS; SUDDEN DEATH;

ANGIOPLASTY, BALLOON, CORONARY; AUTOPSY; CAUSE OF DEATH; FALSE POSITIVE REACTIONS; HUMANS; PREDICTIVE VALUE OF TESTS; REGISTRIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STENTS; TERMINOLOGY AS TOPIC; THROMBOSIS; TIME FACTORS; UNITED STATES;

EID: 79956279647     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2011.01.011     Document Type: Article

References (9)

1. Cutlip DE, Baim DS, Ho KK, et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 2001;103:1967-71. (Pubitemid 32322224)
2. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30. (Pubitemid 40617065)
3. Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation 2007;115:1440-55. (Pubitemid 46648381)
4. Cutlip DE, Windecker S, Mehran R, et al., for the Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-51.
5. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-9. (Pubitemid 46376802)
6. Vranckx P, Kint PP, Morel MA, Van Es GA, Serruys PW, Cutlip DE. Identifying stent thrombosis, a critical appraisal of the Academic Research Consortium (ARC) consensus definitions: a lighthouse and as a toe in the water. EuroIntervention 2008;4Suppl C:C39-44.
7. Weisz G, Leon MB, Holmes DR Jr., et al. Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) trial. J Am Coll Cardiol 2009;53:1488-97.
8. Ellis SG, Stone GW, Cox DA, et al., for the TAXU IV Investigators. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent). J Am Coll Cardiol Intv 2009;2:1248-59.
9. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202. (Pubitemid 43929240)